Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome.

Chokevittaya P, Vichara-Anont I, Krikeerati T, Sompornrattanaphan M, Ruangchira-Urai R, Suratannon N, Thongngarm T, Wongsa C

Open source

DOI
10.1016/j.jdcr.2024.04.003
Published
2024 Jun
Container
JAAD case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jdcr.2024.04.003,
  title = {Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome.},
  author = {Chokevittaya P and Vichara-Anont I and Krikeerati T and Sompornrattanaphan M and Ruangchira-Urai R and Suratannon N and Thongngarm T and Wongsa C},
  year = {2024},
  journal = {JAAD case reports},
  doi = {10.1016/j.jdcr.2024.04.003},
  url = {https://doi.org/10.1016/j.jdcr.2024.04.003}
}

RIS

TY  - JOUR
TI  - Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome.
AU  - Chokevittaya P
AU  - Vichara-Anont I
AU  - Krikeerati T
AU  - Sompornrattanaphan M
AU  - Ruangchira-Urai R
AU  - Suratannon N
AU  - Thongngarm T
AU  - Wongsa C
PY  - 2024
JO  - JAAD case reports
DO  - 10.1016/j.jdcr.2024.04.003
UR  - https://doi.org/10.1016/j.jdcr.2024.04.003
ER  - 

APA

P, C., I, V., T, K., M, S., R, R., N, S., T, T., & C, W. (2024). Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome.. JAAD case reports. https://doi.org/10.1016/j.jdcr.2024.04.003

Source records